Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Keith A, Cengel"'
Autor:
Wei Zou, Haram Kim, Eric S. Diffenderfer, David J. Carlson, Cameron J. Koch, Ying Xiao, BoonKeng K. Teo, Michele M. Kim, James M. Metz, Yi Fan, Amit Maity, Costas Koumenis, Theresa M. Busch, Rodney Wiersma, Keith A. Cengel, Lei Dong
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionRadiation-induced oxygen depletion in tissue is assumed as a contributor to the FLASH sparing effects. In this study, we simulated the heterogeneous oxygen depletion in the tissue surrounding the vessels and calculated the proton FLASH ef
Externí odkaz:
https://doaj.org/article/88f8009ae1c04021a5a855275fbbc650
Autor:
Wendy B. Harris, PhD, Wei Zou, PhD, Chingyun Cheng, PhD, Varsha Jain, MD, PhD, Boon-Keng Kevin Teo, PhD, Lei Dong, PhD, Steven J. Feigenberg, MD, Abigail T. Berman, MD, MSCE, William P. Levin, MD, Keith A. Cengel, MD, PhD, Shannon E. O’Reilly, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 943-950 (2020)
Purpose: The dosimetric parameters used clinically to reduce the likelihood of radiation pneumonitis (RP) for lung cancer radiation therapy have traditionally been V20Gy ≤ 30% to 35% and mean lung dose ≤ 20 to 23 Gy; however, these parameters are
Externí odkaz:
https://doaj.org/article/f76d306debd74e3b852004b3a2f72ff0
Autor:
José Marcio Luna, Hann-Hsiang Chao, Russel T. Shinohara, Lyle H. Ungar, Keith A. Cengel, Daniel A. Pryma, Chidambaram Chinniah, Abigail T. Berman, Sharyn I. Katz, Despina Kontos, Charles B. Simone, II, Eric S. Diffenderfer
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 69-75 (2020)
Background and Purpose: Radiation esophagitis is a clinically important toxicity seen with treatment for locally-advanced non-small cell lung cancer. There is considerable disagreement among prior studies in identifying predictors of radiation esopha
Externí odkaz:
https://doaj.org/article/4f9a3c1e3a2d4d608c79d2cf6344e73b
Autor:
Hongjing Sun, Michele M. Kim, Yi Hong Ong, Andreea Dimoft, Sunil Singhal, Theresa M. Busch, Keith A. Cengel, Timothy C. Zhu
Publikováno v:
Photochemistry and Photobiology. 99:814-825
Photodynamic therapy (PDT) has been used to treat malignant pleural mesothelioma. Current practice involves delivering light to a prescribed light fluence with a point source, monitored by eight isotropic detectors inside the pleural cavity. An infra
Autor:
Charles B. Simone, Nikhil Yegya-Raman, Shwetha Manjunath, Vivek Verma, Jacob E. Shabason, Lee Xu, Keith A. Cengel, William P. Levin, Abigail T. Berman, John P. Christodouleas, Charu Aggarwal, Roger B. Cohen, Corey J. Langer, Taine T. Pechet, Sunil Singal, John C. Kucharczuk, Ramesh Rengan, Steven J. Feigenberg
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Michelle Iocolano, Kristine N. Kim, Abigail Doucette, Roger B. Cohen, Kyle W. Robinson, William P. Levin, Keith A. Cengel, Brian Lally, Manuj Agarwal, Christopher A. D'Avella, Melina E. Marmarelis, John A. Kosteva, Aditi P. Singh, Christine A. Ciunci, Charu Aggarwal, Abigail T. Berman, Corey J. Langer, Steven J. Feigenberg
Publikováno v:
Clinical Lung Cancer.
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Supplemental Tables 1-6 Supplemental Table 1. Results of some recent trials of chemotherapy in MPM. Supplemental Table 2. Post-Trial Therapies Supplemental Table 3. Characteristics of Patients Selected for Flow Cytometry Analysis Supplemental Table 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2dbb2844eaa01ee4617c857fe022fb
https://doi.org/10.1158/1078-0432.22457066.v1
https://doi.org/10.1158/1078-0432.22457066.v1
Autor:
Gary D. Kao, Charles B. Simone, Jay F. Dorsey, Stephen M. Hahn, Keith A. Cengel, William Levin, Abigail Berman, Sam Swisher-McClure, Chimbu Chinniah, Amberly Mendes, Louise A. Aguarin, Samuel R. Jean-Baptiste, Steven J. Feigenberg, Melissa A. Frick
Purpose:Although stereotactic body radiotherapy (SBRT) is effective in early-stage non–small cell lung cancer (NSCLC), approximately 10%–15% of patients will fail regionally and 20%–25% distantly. We evaluate a novel circulating tumor cell (CTC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4e6c41dbeb32a4becc93696d615ee5
https://doi.org/10.1158/1078-0432.c.6529122.v1
https://doi.org/10.1158/1078-0432.c.6529122.v1
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Purpose: “In situ vaccination” using immunogene therapy has the ability to induce polyclonal antitumor responses directed by the patient's immune system.Experimental Design: Patients with unresectable malignant pleural mesothelioma (MPM) received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2810b59165230c7ab9401119d8a2979b
https://doi.org/10.1158/1078-0432.c.6523496.v1
https://doi.org/10.1158/1078-0432.c.6523496.v1
Autor:
Gary D. Kao, Charles B. Simone, Jay F. Dorsey, Stephen M. Hahn, Keith A. Cengel, William Levin, Abigail Berman, Sam Swisher-McClure, Chimbu Chinniah, Amberly Mendes, Louise A. Aguarin, Samuel R. Jean-Baptiste, Steven J. Feigenberg, Melissa A. Frick
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35317e02cb5dc1bdb97de2c62a5443a
https://doi.org/10.1158/1078-0432.22475607
https://doi.org/10.1158/1078-0432.22475607